KANJINTI

Company:
Amgen Ireland Ltd
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
Trastuzumab
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/18/1281/001

150 milligram(s)

L01FD01

Pdr/Conc/Soln for Infusion

EU/1/18/1281/002

420 milligram(s)

L01FD01

Pdr/Conc/Soln for Infusion